These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9361668)

  • 41. Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men.
    Nestler JE; Beer NA; Jakubowicz DJ; Colombo C; Beer RM
    J Clin Endocrinol Metab; 1995 Feb; 80(2):700-6. PubMed ID: 7852539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjects.
    Legrain S; Massien C; Lahlou N; Roger M; Debuire B; Diquet B; Chatellier G; Azizi M; Faucounau V; Porchet H; Forette F; Baulieu EE
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3208-17. PubMed ID: 10999810
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differences due to dehydroepiandrosterone (DHEA) feeding affecting dehydroepiandrosterone sulfate secretion in golden Syrian hamsters.
    Maeda Y; Nagatomo J; Sueta H; Tanaka S; Ota Y; Shiotsuki H; Eto T; Kai M; Kondo K; Chijiiwa K
    Horm Metab Res; 2004 Feb; 36(2):107-10. PubMed ID: 15002061
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
    N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of atherosclerosis by administration of dehydroepiandrosterone. A study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury.
    Gordon GB; Bush DE; Weisman HF
    J Clin Invest; 1988 Aug; 82(2):712-20. PubMed ID: 2969922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dehydroepiandrosterone and diseases of aging.
    Watson RR; Huls A; Araghinikuam M; Chung S
    Drugs Aging; 1996 Oct; 9(4):274-91. PubMed ID: 8894525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Science of intracrinology in postmenopausal women.
    Labrie F; Bélanger A; Pelletier G; Martel C; Archer DF; Utian WH
    Menopause; 2017 Jun; 24(6):702-712. PubMed ID: 28098598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects.
    Martina V; Benso A; Gigliardi VR; Masha A; Origlia C; Granata R; Ghigo E
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [DHEA: hormone as antiaging remedies].
    Yamada Y; Sekihara H
    Nihon Ronen Igakkai Zasshi; 2003 Sep; 40(5):421-8. PubMed ID: 14579706
    [No Abstract]   [Full Text] [Related]  

  • 50. Na+ K(+)-ATPase activity in response to exogenous dehydroepiandrosterone administration in aging rat brain.
    Taha A; Mishra M; Baquer NZ; Sharma D
    Indian J Exp Biol; 2008 Dec; 46(12):852-4. PubMed ID: 19245184
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of plasma dehydroepiandrosterone-sulfate levels with endothelial function in postmenopausal women with coronary risk factors.
    Akishita M; Hashimoto M; Ohike Y; Ogawa S; Iijima K; Eto M; Ouchi Y
    Hypertens Res; 2008 Jan; 31(1):69-74. PubMed ID: 18360020
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study.
    Laughlin GA; Barrett-Connor E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3561-8. PubMed ID: 11061502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dehydroepiandrosterone and/or its metabolites: possible androgen receptor antagonistic effects on digitized mammographic breast density in normal breast tissue of postmenopausal women.
    Lundström E; Carlström K; Naessen S; Söderqvist G
    Horm Mol Biol Clin Investig; 2018 Aug; 35(1):. PubMed ID: 30144382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical significance of dehydroepiandrosterone (DHEA) supplement therapy].
    Yanase T
    Nihon Naika Gakkai Zasshi; 2003 Sep; 92(9):1701-4. PubMed ID: 14560605
    [No Abstract]   [Full Text] [Related]  

  • 55. DHEA for postmenopausal women: a review of the evidence.
    Panjari M; Davis SR
    Maturitas; 2010 Jun; 66(2):172-9. PubMed ID: 20089375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adrenal androgens and intracrinology.
    Labrie F
    Semin Reprod Med; 2004 Nov; 22(4):299-309. PubMed ID: 15635498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dehydroepiandrosterone administration in humans: evidence based?
    Bovenberg SA; van Uum SH; Hermus AR
    Neth J Med; 2005 Sep; 63(8):300-4. PubMed ID: 16186639
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A validated LC-MS/MS method for the sensitive quantitation of serum 7alpha hydroxy-, 7beta hydroxy- and 7keto-dehydroepiandrosterone using a novel derivatization reagent.
    Ke Y; Gonthier R; Simard JN; Labrie F
    Steroids; 2016 Apr; 108():112-7. PubMed ID: 26855361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulfate (DHEA-S)].
    Adachi M; Nawata H
    Nihon Rinsho; 1999 Dec; 57 Suppl():157-61. PubMed ID: 10778088
    [No Abstract]   [Full Text] [Related]  

  • 60. Dehydroepiandrosterone to enhance physical performance: myth and reality.
    Hahner S; Allolio B
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):127-39, x. PubMed ID: 20122454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.